Search Orphan Drug Designations and Approvals
-
| Generic Name: | Humanized IgG4 S228P monoclonal antibody targeting the cis conformation of the phosphorylated Thr231-Pro232 motif in tau |
|---|---|
| Date Designated: | 06/16/2020 |
| Orphan Designation: | Treatment of Progressive supranuclear palsy |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Pinteon Therapeutics Inc. 1188 Centre Street Newton Centre, Massachusetts 02459 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







